BNP PARIBAS FINANCIAL MARKETS - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 103 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.90 and the average weighting 0.2%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$892
-98.6%
2,923
-96.9%
0.00%
Q2 2023$65,504
+11.2%
93,045
+41.6%
0.00%
Q1 2023$58,928
+621.4%
65,702
+849.0%
0.00%
Q4 2022$8,169
-100.0%
6,923
-46.5%
0.00%
Q3 2022$97,498,000
+66.3%
12,948
+39.1%
0.00%
Q2 2022$58,634,000
+134.3%
9,307
+208.7%
0.00%
Q1 2022$25,024,000
-70.5%
3,015
-81.5%
0.00%
Q4 2021$84,748,000
+86.2%
16,329
+139.6%
0.00%
Q3 2021$45,518,000
+44.6%
6,814
+84.5%
0.00%
Q2 2021$31,473,000
-15.0%
3,694
-11.7%
0.00%
Q1 2021$37,028,000
-52.2%
4,184
-33.6%
0.00%
Q4 2020$77,464,000
+43.9%
6,303
-4.7%
0.00%
Q3 2020$53,822,000
+350.3%
6,612
+431.1%
0.00%
Q2 2020$11,952,000
-75.6%
1,245
-82.7%
0.00%
Q1 2020$49,048,000
+21.9%
7,213
+167.1%
0.00%
Q4 2019$40,230,000
+32.6%
2,700
-8.8%
0.00%
Q3 2019$30,340,000
+4785.7%
2,960
+4598.4%
0.00%
Q1 2018$621,000
-29.4%
630.0%0.00%
Q4 2017$879,000
+26.8%
630.0%0.00%
Q3 2017$693,000
+39.2%
630.0%0.00%
Q2 2017$498,000
+333.0%
63
+530.0%
0.00%
Q1 2017$115,000
-82.7%
10
-82.5%
0.00%
Q4 2016$664,000
-82.4%
57
-79.8%
0.00%
Q3 2016$3,776,000
+39.1%
282
+105.8%
0.00%
Q2 2016$2,715,0001370.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
P.A.W. CAPITAL CORP 540,000$4,482,0004.68%
Knoll Capital Management, LLC 694,232$5,762,0003.62%
Telemetry Investments, L.L.C. 213,000$1,768,0002.79%
ACT CAPITAL MANAGEMENT, LLC 250,000$2,075,0002.20%
VR Adviser, LLC 1,469,767$12,199,0001.98%
INTERWEST VENTURE MANAGEMENT CO 560,990$4,656,0001.78%
683 Capital Management, LLC 3,375,000$28,013,0001.50%
Trellus Management Company, LLC 300,000$2,490,0001.45%
Altium Capital Management LP 440,000$3,652,0001.22%
CAXTON CORP 116,884$970,0001.21%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders